Surveillance of HFMD in Pediatric Outpatients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 10
SponsorUniversity Hospital, Clermont-Ferrand
About this trial
The aims of this prospective multicentric study is to determine the types of enteroviruses (EVs) responsible for hand, foot and mouth disease (HFMD) or herpangina in children seen within an ambulatory setting :
* to detect an EV-A71 epidemic or another type associated with atypical forms of the disease at an early stage * to describe and compare the epidemiological, demographic, clinical and virological characteristics of these infections between the different types of EV.
Eligibility criteria
Qualifiers
Children aged 0 to 10 years presenting with HFMD or herpangina
Disqualifiers
Refusal to participate by holders of parental authority
Refusal to participate for children over 3 years of age
Trial design
Treatments tested in this trial
- Throat/buccal swab sample
Treatment groups
3,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov